Skip to content
Back to Guavy Wire
Crypto

Injective Earns SEC Transfer Agent Status, Bolsters Institutional Tokenization Push

Instruments
INJ
Share

Injective, a Layer 1 network, has expanded its tokenization push by becoming an SEC-registered transfer agent. This move positions Injective as a venue for institutional tokenization and adds regulated securities infrastructure to its blockchain.

The registration will allow processes such as transfers, distributions, and shareholder administration to use distributed-ledger infrastructure while remaining compatible with U.S. securities rules. This is the first of its kind for a Layer 1 blockchain.

Injective has been pushing further into enterprise finance, including launching markets tied to digital-asset treasury companies, public equities, and shares of private companies such as SpaceX and OpenAI. It has also introduced Injective Mint Alpha, a platform for issuing tokenized assets.

The project is designed to issue, transfer, administer, and settle trade receivables generated through international commerce. Injective's strategy involves targeting four different asset classes: institutional funds, public equities, private company shares, and enterprise receivables.

More on Crypto

Disclaimer: Guavy is a data and market intelligence provider, not an investment adviser. The information, signals, and market analysis provided by the Guavy API and related services are for informational purposes only and are not intended as financial advice, investment recommendations, or an endorsement of any particular trading strategy. Trading in volatile markets, including cryptocurrency, carries significant risk and may not be suitable for all investors. Past performance is not indicative of future results. Users should consult with a qualified financial professional before making any investment decisions. Guavy makes no guarantee of trading profits or financial returns.

Market sentiment intelligence for apps, funds & agents

Location

729 55 Ave SW
Calgary AB T2V 0G4
Canada

© 2026 Guavy Inc